Wrap Text
Mediclinic Southern Africa announces approval for the acquisition of Matlosana hospitals
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic”, the “Company” or the “Group”)
07 February 2020
Mediclinic Southern Africa announces approval for the acquisition of Matlosana hospitals
Mediclinic International, a diversified private healthcare services group, today announces that its
Mediclinic Southern Africa division has received approval for its proposed acquisition of a controlling share
in Matlosana Medical Health Services Proprietary Limited (“Matlosana”), based in Klerksdorp in the
North-West Province of South Africa. The acquisition includes two multi-disciplinary hospitals namely the
185-bed Wilmed Park Hospital and the 62-bed Sunningdale Hospital. In addition, the acquisition includes
a 51% share in the 50-bed Parkmed Neuro Clinic psychiatric hospital.
Mediclinic Southern Africa initiated the acquisition process in 2015. Following various approval processes,
the matter was referred to the Competition Appeal Court which has now ruled in favour of the acquisition,
with an expected effective date around the middle of 2020.
Koert Pretorius, Chief Executive Officer of Mediclinic Southern Africa, said:
“We are delighted to expand our current care offering within the North West Province of South Africa.
Mediclinic remains focused on delivering high-quality healthcare services across the continuum of care and
an excellent client experience. The Wilmed Park Hospital has consistently been recognised as one of the
best hospitals within the North West Province and we are excited to work with the many doctors, nurses
and staff at Matlosana to build on that reputation.
“The existing management team at the hospital will remain in place to ensure that the business continues
to deliver the same high levels of care under the Mediclinic brand, as we expand our focus on delivering
accessible, quality care at the best possible value for our patients.”
Marius van Tonder, CEO of Matlosana Health Services Proprietary Limited, said:
“We look forward to a new era alongside Mediclinic where we have the opportunity to integrate the
strengths of our two organisations towards providing expanded access to expertise for our patients.”
About Mediclinic International plc
Mediclinic is an international private healthcare services group, established in South Africa in 1983, with
divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates.
The Group’s core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum
of care in such a way that the Group will be regarded as the most respected and trusted provider of
healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its
markets.
As at 1 February, Mediclinic comprised 77 hospitals, five sub-acute hospitals, 14 day case clinics and 22
outpatient clinics. Hirslanden operated 17 hospitals, two day case clinics and three outpatient clinics in
Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operations included 53
hospitals (three of which in Namibia), five sub-acute hospitals and 10 day case clinics (four of which
operated by Intercare) across South Africa, and more than 8 500 inpatient beds; and Mediclinic Middle
East operated seven hospitals, two day case clinics and 19 outpatient clinics with more than 900 inpatient
beds in the United Arab Emirates.
The Company’s primary listing is on the London Stock Exchange (“LSE”) in the United Kingdom, with
secondary listings on the JSE Ltd (“JSE”) in South Africa and the Namibian Stock Exchange (“NSX”) in
Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group
based in the United Kingdom and listed on the LSE.
About Matlosana Health Services Proprietary Limited
Matlosana Medical Health Services Proprietary Limited is a privately owned holding company of 3 hospital
facilities in Klerksdorp, North West Province, South Africa. The Matlosana Group managed to attract top
doctors, nurses and other medical support staff to Klerksdorp and renders world class healthcare services
to their patients.
For further information, please contact:
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Ben Atwell/Ciara Martin – United Kingdom
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
Date: 07-02-2020 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
